Earnings Review - UnitedHealth

LONDON, February 3, 2015 /PRNewswire/ --

Investor-Edge.com has issued free earnings review on UnitedHealth Group Inc. (NYSE: UNH). On January 21, 2015, the company reported its Q4 FY14 and full-year FY14 financial results (period ended December 31, 2014). Click on http://get.Investor-Edge.com/pdf/?c=UnitedHealth&d=03-Feb-2015&s=UNH to read our free earnings review on UnitedHealth Group Inc. (UnitedHealth). During FY14, the company's total revenue and operating earnings grew by 7% Y-o-Y, each. Further, UnitedHealth's cash flows from operations increased 15% Y-o-Y in FY14. Our free coverage report can be accessed at:

http://get.Investor-Edge.com/pdf/?c=UnitedHealth&d=03-Feb-2015&s=UNH

Earnings Overview 

During Q4 FY14, UnitedHealth reported total revenue of $33.43 billion compared to $31.12 billion in Q4 FY13. Analysts from Bloomberg had expected net revenue of $33.13 billion in Q4 FY14. Moreover, UnitedHealth's Optum health Services business' revenue grew by 23% Y-o-Y to $12.88 billion in Q4 FY14. Free research on UNH can be downloaded in PDF format at:

http://get.Investor-Edge.com/pdf/?c=UnitedHealth&d=03-Feb-2015&s=UNH

In Q4 FY14, the company's earnings from operations improved to $2.77 billion from $2.45 billion in Q4 FY13. In Q4 FY14, net earnings attributable to UnitedHealth common shareholders increased to $1.51 billion, or $1.55 per diluted share, from $1.43 billion, or $1.41 per diluted share, in Q4 FY13. Bloomberg analysts had expected the company to report net earnings attributable to UnitedHealth common shareholders of $1.46 billion, or $1.50 per diluted share, in Q4 FY14. During the reported quarter, the company's reported cash from operations of $2.4 billion.

For FY14, UnitedHealth's total revenue was $130.47 billion compared to $122.49 billion in FY13. Analysts from Bloomberg had expected total revenue of $130.19 billion in FY14. Furthermore, UnitedHealth's Optum health Services business revenue grew by $9.63 billion, or 25% Y-o-Y to $47.75 billion in FY14. Sign up and read the free analyst's notes on UNH at:

http://get.Investor-Edge.com/pdf/?c=UnitedHealth&d=03-Feb-2015&s=UNH

During FY14, UnitedHealth's earnings from operations increased to $10.27 billion from $9.62 billion in FY13. Net earnings attributable to UnitedHealth common shareholders for FY14 stood at $5.62 billion, or $5.70 per diluted share, compared to $5.63 billion, or $5.50 per diluted share, in FY13. Bloomberg analysts had expected the company to report net earnings attributable to UnitedHealth common shareholders of $5.57 billion, or $5.65 per diluted share, in FY14.

UnitedHealth's cash from operations increased to $8.05 billion in FY14 from $6.99 billion in FY13. In FY14, the company repurchased $4 billion in stock in at an average price of approximately $82.60 per share. The company also paid $1.4 billion in shareholder dividends, up 29% Y-o-Y.

Stephen J. Hemsley, CEO of UnitedHealth, said that the company entered 2015 with a positive outlook and rising business momentum. He asserted that steady innovation and year by year advances in the quality, breadth and value of services to employers, government sponsors, consumers and care providers are creating opportunities for revenue and earnings growth in traditional and new markets.

For FY15, UnitedHealth management expects revenue in a range of $140.5 billion to $141.5 billion and anticipates rising net earnings per share growth, to the range $6.00 to $6.25 per share. The company expects cash flows from operations in a range of $8.0 billion to $8.4 billion for FY15. Visit Investor-Edge and access the latest research on UNH at:

http://get.Investor-Edge.com/pdf/?c=UnitedHealth&d=03-Feb-2015&s=UNH

Stock Performance 

On the day of the earnings release, January 21, 2015, UnitedHealth's stock ended the session at $109.32, up 3.50%. Since then, the stock has moved both ways with losses outperforming the gains. On the last close, Monday, February 02, 2015, the company's shares finished at $107.29, up 0.98% for the day. The stock vacillated between $105.07 and $107.34 during the session. A total of 4.66 million shares were traded which was above its three months average volume of 4.12 million shares. Over the last one month and previous three months, the company's shares have gained 6.46% and 12.92%, respectively. Further, the stock has rallied 48.44% in the past one year. Shares in UnitedHealth are trading above their 50-day and 200-day moving averages of $102.13 and $88.28, respectively. Furthermore, the stock traded at a PE ratio of 19.23.

Sneak Peek to Corporate Insider Trading 

In the last one month, there were 11 corporate insider transactions made by four individuals. Between January 22 and January 29, 2015, a total of 32,415 shares have been purchased at an average price of $48.99 per share and for a total value of $1.59 million. During the stated period, a total of 32,415 shares were also disposed at an average price of $110.35 per share and for a total of $3.58 million. On January 22, 2015, Gail R. Wilensky, Director at UnitedHealth, bought 20,850 shares at an average price of $50.38 per share and sold an equal number of shares at a price of $109.75 per share. On January 26, 2015, William C. Ballard, Jr., Director at UnitedHealth, purchased 10,000 shares at a price $47.92 per share and sold an equal number of shares at a price $111.66 per share. Additionally, on January 29, 2015, Richard T. Burke, Director at UnitedHealth, bought 940 shares at a price of $45.34 per share and sold an equal number of shares at a price of $108.15 per share. Complimentary in-depth research on UNH is available at:

http://get.Investor-Edge.com/pdf/?c=UnitedHealth&d=03-Feb-2015&s=UNH

About Investor-Edge.com 

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

===============

EDITOR'S NOTES:

===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED